COPENHAGEN – Given the central role of Copenhagen in the industrialization of insulin production almost a century ago and given its ongoing strength in diabetes through the presence of global leader Novo Nordisk A/S, it was fitting that the region's next generation of contenders was invited to pitch its wares at a metabolic disease showcase on the final day of BIO-Europe.